Fig. 3From: An open label study of the safety and efficacy of a single dose of weekly chloroquine and azithromycin administered for malaria prophylaxis in healthy adults challenged with 7G8 chloroquine-resistant Plasmodium falciparum in a controlled human malaria infection modelExposure-time curves for AZ, CQ and CQm in protected and non-protected subgroups of CQAZ groupBack to article page